K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cells.
Nakai R, Iida S, Takahashi T, Tsujita T, Okamoto S, Takada C, Akasaka K, Ichikawa S, Ishida H, Kusaka H, Akinaga S, Murakata C, Honda S, Nitta M, Saya H, Yamashita Y.
Cancer Res. 2009 May 1;69(9):3901-9. Epub 2009 Apr 7.PMID: 19351824 [PubMed - indexed for MEDLINE]Related articles